ipilimumabnivolumabmKRAS-VAXoxaliplatinbotensilimabbalstilimabirinotecan
… with an objective response.Conclusions mKRAS-VAX combined with ipilimumab and nivolumab was well-tolerated and resulted in clinical respo…
1articles mentioning drugs
8drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: mKRAS-VAX ×
mKRAS-VAX
This drug is selected. Its supporting articles are shown below.